ATOS

Atossa Therapeutics, Inc.$5.52+0.07 (+1.28%)

Prev Close$5.45·MCap$39.4M·P/E—·Vol28.2K·Yield—

▲

Buys (12M)

$9.9K

▼

Sells (12M)

$0.00

◆

Net Activity

Net Buyer

$9.9K

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at Atossa Therapeutics, Inc. (ATOS) has been exclusively buying, with 1 insider purchase totaling $9.9K and 0 insider sales totaling $0.00. The most recent insider transaction was by QUAY STEVEN C (President & CEO), who purchased $9.9K worth of shares on May 21, 2025. Atossa Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $39.4M.

ATOS Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value
May 21, 2025	QUAY STEVEN C	President & CEO	Buy	11,239	$0.88	$9.9K
Mar 26, 2025	Remmel H. Lawrence	Director	Buy	10,000	$0.70	$7.0K
Apr 10, 2024	Finn Jonathan	Director	Buy	25,000	$1.77	$44.3K
Nov 15, 2023	WEAVER GREGORY L	Former EVP, CFO, & Director	Sell	50,000	$0.65	$32.5K0.6% OS
Jun 20, 2023	WEAVER GREGORY L	EVP & CFO	Buy	50,000	$0.97	$48.5K0.6% OS
Jul 2, 2021	WEAVER GREGORY L	Director	Sell	164,581	$5.86	$965.2K1.9% OS

ATOS Insider Buying Activity

The following table shows recent insider purchases of Atossa Therapeutics, Inc. (ATOS) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value
May 21, 2025	QUAY STEVEN C	President & CEO	Buy	11,239	$0.88	$9.9K
Mar 26, 2025	Remmel H. Lawrence	Director	Buy	10,000	$0.70	$7.0K
Apr 10, 2024	Finn Jonathan	Director	Buy	25,000	$1.77	$44.3K
Jun 20, 2023	WEAVER GREGORY L	EVP & CFO	Buy	50,000	$0.97	$48.5K0.6% OS

ATOS Insider Selling Activity

The following table shows recent insider sales of Atossa Therapeutics, Inc. (ATOS) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Nov 15, 2023	WEAVER GREGORY L	Former EVP, CFO, & Director	Sell	50,000	$0.65	$32.5K0.6% OS	0
Jul 2, 2021	WEAVER GREGORY L	Director	Sell	164,581	$5.86	$965.2K1.9% OS	0